;The PI will serve as the Director of the Administrative Core. The current Administrative Core of CCRTD Is composed of a scientific director, manager of administrative services, an assistant program manager and a senior staff assistant. It serves as an intermediate between the cancer researchers and the bureaucracy of the University. The main objectives of the Administrative Core are a) to provide leadership and focal point for organization of all activities of the proposed Center of Excellence;b) to serve as a medium between the components of the proposed Center of Excellence and NIMHD;and c) to provide financial management, purchasing and other administrative services to the faculty and staff of the proposed Center of Excellence. We will utilize current advisory committees to oversee the activities of the center. These are the Institutional Advisory Committee (lAC), the External Advisory Committee (EAC), the Local External Advisory Committee (LEAC), and the Community Relations Advisory Board. The Core Director will oversee all day-to-day administrative responsibilities of proposed center which include implementing the policies of the program after consultation and guidance from the lAC, EAC and the LEAC. The Administrative Core is designed to maintain a strong and seamless communication with members of CCRTD and their research staff. The administrative staff provides scientists with the services of post-award management duties such as establishment of University budget accounts for each grant, processing purchase requisitions for each grant. Interacting with the staffs of the Offices of Grants and Contracts, Research and Sponsored Programs, and Purchasing and Accounts Payable and preparing monthly budget printouts for each scientist. The Administrative Core also organizes weekly group meetings, weekly invited speaker series and annual symposia. The Administrative Core will continue to coordinate the activities of all components and cores of the Center of Excellence.

Public Health Relevance

The administrative core provides support for all biomedical researchers who are pail of the Center for Cancer Research and Therapeutic Development. All investigators are engaged in research on prostate cancer and other health related issues.

National Institute of Health (NIH)
National Institute on Minority Health and Health Disparities (NIMHD)
Exploratory Grants (P20)
Project #
Application #
Study Section
Special Emphasis Panel (ZMD1-RN)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Clark Atlanta University
United States
Zip Code
Muniyan, Sakthivel; Chou, Yu-Wei; Tsai, Te-Jung et al. (2015) p66Shc longevity protein regulates the proliferation of human ovarian cancer cells. Mol Carcinog 54:618-31
Brown, Shanora G; Knowell, Ashley E; Hunt, Aisha et al. (2015) Interferon inducible antiviral MxA is inversely associated with prostate cancer and regulates cell cycle, invasion and Docetaxel induced apoptosis. Prostate 75:266-79
Smith, Basil; Randle, Diandra; Mezencev, Roman et al. (2014) Camalexin-induced apoptosis in prostate cancer cells involves alterations of expression and activity of lysosomal protease cathepsin D. Molecules 19:3988-4005
Burton, Liza J; Barnett, Petrina; Smith, Basil et al. (2014) Muscadine grape skin extract reverts snail-mediated epithelial mesenchymal transition via superoxide species in human prostate cancer cells. BMC Complement Altern Med 14:97
Mandal, S; Abebe, F; Chaudhary, J (2014) -174G/C polymorphism in the interleukin-6 promoter is differently associated with prostate cancer incidence depending on race. Genet Mol Res 13:139-51
Smith, Bethany N; Burton, Liza J; Henderson, Veronica et al. (2014) Snail promotes epithelial mesenchymal transition in breast cancer cells in part via activation of nuclear ERK2. PLoS One 9:e104987
Gryder, Berkley E; Akbashev, Michelle J; Rood, Michael K et al. (2013) Selectively targeting prostate cancer with antiandrogen equipped histone deacetylase inhibitors. ACS Chem Biol 8:2550-60
Chetram, Mahandranauth A; Hinton, Cimona V (2013) ROS-mediated regulation of CXCR4 in cancer. Front Biol (Beijing) 8:
Strong, Nicole; Millena, Ana C; Walker, Lindsey et al. (2013) Inhibitor of differentiation 1 (Id1) and Id3 proteins play different roles in TGFýý effects on cell proliferation and migration in prostate cancer cells. Prostate 73:624-33
Chetram, Mahandranauth A; Bethea, Danaya A; Odero-Marah, Valerie A et al. (2013) ROS-mediated activation of AKT induces apoptosis via pVHL in prostate cancer cells. Mol Cell Biochem 376:63-71

Showing the most recent 10 out of 21 publications